Methotrexate in rheumatoid arthritis: Studies with animal models

Advances in Enzyme Regulation

Volumn 29, Issue C, 1989, Pages 247-265

  Kerwar, S S ^a   Oronsky, A L ^a  

^a Connective Tissue and Arthritis Research Unit Department of Inflammation and Immunology Medical Research Division American Cyanamid Company Lederle Laboratories Pearl River New York 10965 USA ^*

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; INTERLEUKIN 1; INTERLEUKIN 2; METHOTREXATE;

ANIMAL; ARTHRITIS; ARTICLE; BIOSYNTHESIS; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; FEMALE; MALE; METABOLISM; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; RAT; RAT STRAIN; RHEUMATOID ARTHRITIS; SPLEEN;

ANIMAL; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERLEUKIN-1; INTERLEUKIN-2; MALE; METHOTREXATE; NEUTROPHILS; RATS; RATS, INBRED LEW; SPLEEN; SUPPORT, NON-U.S. GOV'T;

EID: 0024812605     PISSN: 00652571     EISSN: None     Source Type: Journal    
DOI: 10.1016/0065-2571(89)90105-2     Document Type: Article

References (60)

1. Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and in psoriasis
2. Methotrexate therapy in rheumatoid arthritis: Current status
3. Methotrexate in rheumatoid arthritis
4. Methotrexate in rheumatoid arthritis
5. Methotrexate and rheumatoid arthritis
6. Treatment of the patient with rheumatoid arthritis refractory to standard therapy
7. Treatment with low dose methotrexate in chronic polyarthritis
8. Methotrexate in rheumatoid arthritis: an update
9. Short term efficacy of methotrexate in the treatment of rheumatoid arthritis
10. Long term methotrexate therapy in rheumatoid arthritis, a review
11. Efficacy of low dose methotrexate in rheumatoid arthritis
12. A controlled 2 center trial of parenteral methotrexate therapy for refractory rheumatoid arthritis
13. Comparison of low dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial
14. Weekly pulse methotrexate in rheumatoid arthritis
15. Twenty-four week double blind crossover study of methotrexate in rheumatoid arthritis
16. Long term prospective trial of low dose methotrexate in rheumatoid arthritis
17. Immunologic studies of rheumatoid arthritis patients treated with methotrexate
18. The safety and efficacy of the use of methotrexate in long term therapy for rheumatoid arthritis
19. A long term prospective study of the use of methotrexate in rheumatoid arthritis: Update after a mean of fifty-three months
20. Pulse methotrexate therapy in rheumatoid arthritis. A controlled prospective roentgenographic study
21. Studies on the effect of low dose methotrexate in rat adjuvant arthritis
22. Studies on the effect of mitoxantrone on adjuvant arthritis in rats
23. Arthritis in rats after systemic injection of streptococcal cells or cell walls
24. Suppression of adjuvant arthritis by antibodies specific to collagen type II
25. Radiographic analysis of arthritis in rats after systemic administration of streptococcal cell walls
26. Methotrexate suppresses passive adjuvant arthritis: Studies on the metabolism of methotrexate in mononuclear cells derived from normal and adjuvant arthritic rats
27. Studies on the effect of methotrexate on macrophage function
28. Regulation of polyglutamate accumulation in vitro: Effect of cellular folate content
29. Studies on the effect of d-penicillamine, gold thioglucose and methotrexate on streptococcal cell wall arthritis
30. T cell growth factor: parameters of production and a quantitative micro assay for activity
31. The formation of a structure with the features of synovial lining by subcutaneous injection of air An in vivo tissue culture system
32. Administration of group A streptococcal cell walls to rats induces an IL-2 deficiency
33. Methotrexate in adjuvant arthritis
34. 4, a potent chemokinetic and aggregating agent released from polymorphonuclear leukocytes
35. a
36. a
37. Relationship between animal and human doses
38. Methotrexate inhibits polymorphonuclear leukocyte chemotaxis in psoriasis
39. Inhibition of neutrophil chemotaxis in methotrexate treated rheumatoid arthritis patients
40. Streptococcal cell wall arthritis: studies with nude (athymic) inbred Lewis rats
41. IL-2 deficiency in rheumatoid arthritis and systemic lupus erythematosus
42. IL-2 in rheumatoid arthritis: production of and response to IL-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood
43. Inhibitor of IL-2 in rheumatoid synovial fluid
44. Immunomodulation by low dose methotrexate: methotrexate selectively inhibits Lyt2+ cells in murine graft versus host disease
45. Methotrexate increases production of IL-2
46. Restoration of diminished T cell function in adjuvant induced arthritis in rats
47. Bacterial cell wall induced immunosuppression. Role of transforming growth factor β
48. Methotrexate inhibits macrophage activation as well as vascular and cellular inflammatory events in rat adjuvant arthritis
49. Interleukin-1β is structurally related to dihydrofolate reductase: Effect of methotrexate on IL-1
50. Dihydrofolate reductase
51. The effect of leucovorin on methotrexate therapy in rheumatoid arthritis patients
52. Mechanism of growth inhibition by methotrexate
53. Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates
54. The effect of methotrexate in intracellular folate pools in human MCF-7 breast cancer cells
55. Lack of inhibition of thymidylate synthase activity with low dose oral methotrexate in rheumatoid arthritis
56. Synthesis and biological properties of 5,10-dideaza 5,6,7,8 tetrahydrofolic acid
57. Synthesis of the antileukemic agents 5,10 dideazaacemenopterin and 5,10 dideaza 5,6,7,8 tetrahydroaminopterin
58. Beneficial effects of leucovorin after methotrexate treatment in rheumatoid arthritis: a case report
59. The use of leucovorin after low dose methotrexate in patients with rheumatoid arthritis
60. Concurrent use of folinic acid and methotrexate in rheumatoid arthritis